The ESCMID Study Group for Tick-Borne Diseases (ESGBOR) plays a pivotal role in the management of tick-borne diseases such as Lyme borreliosis. By uniting pan-European experts, ESGBOR is committed to:
ESGBOR Newsletter April 2023, 4 April 2023
ESGBOR Newsletter November 2023, 24 November 2023
Identification of potential biomarkers in active Lyme borreliosis.
Tjernberg I, Lager M, Furset Jensen G, Eikeland R, Nyman D, Brudin L, Henningsson AJ. PLoS ONE. 2023;18(6):e0287586.
International symposium on tick-borne pathogens and disease
22-25 October 2023, Vienna, Austria
If you have questions or comments for our study group, we warmly invite you to contact us!